Claim check · Safety
BPC-157 and safety in humans
Claim (representative wording, not a quotation): BPC-157 has been shown to be safe in people.
Plain-English answer
WPF found only very small human reports: a two-person intravenous pilot with no adverse effects reported, and a retrospective knee-pain series that reported pain outcomes rather than safety data. That cannot show safety, and the one registered safety trial has no posted results.
Verdict: Insufficient evidence. The sources WPF read neither support nor contradict the claim. The page states exactly what is missing and where WPF looked.
Scope
- Population or organism
- Humans: two adults in an intravenous pilot; 16 patients followed in a retrospective knee-pain series (12 of them treated with BPC-157 alone); a registered phase 1 trial with no posted results
- Study design
- Uncontrolled pilot and retrospective case series; a registered phase 1 trial with no posted results
- Boundary
- Short-term tolerability in the reported people. This check does not assess long-term, repeated-dose, injectable-product-quality or interaction risks.
Strongest evidence
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study (Altern Ther Health Med, 2025; PMID 40131143) (Peer-reviewed paper)
Population or organism: 2 healthy adults (58 and 68 years old) at one private clinic, each previously exposed to BPC-157
Design: Uncontrolled pilot: intravenous infusions on two consecutive days, with blood work before and after
Where in the source: Abstract, Participants and Results: no measurable effects on the tested heart, liver, kidney, thyroid and glucose markers; no side effects reported. The authors conclude that the study "showed the safety of BPC-157 in humans"; this check does not accept that conclusion from two participants.
Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain (Altern Ther Health Med, 2021; 27(4):8-13; PMID 34324435) (Peer-reviewed paper)
Population or organism: Adults with knee pain from several causes at one clinic: 17 patients in the chart review, 16 reached by telephone, 12 of them treated with BPC-157 alone
Design: Retrospective, uncontrolled case series (chart review and telephone follow-up). It assessed knee pain, not safety
Where in the source: Abstract, Methods and Results: patients rated their own pain and the benefit; the abstract reports improvement outcomes and no adverse-event data. Abstract only: WPF did not read the full text.
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (HSS J, 2025; PMID 40756949; PMC12313605) (Systematic review)
Population or organism: 36 studies: 35 preclinical, 1 clinical (the knee-pain case series above, reported as 12 patients)
Design: Systematic review of English-language literature to 3 June 2024; the clinical study was retrospective
Where in the source: Abstract, Results: "No clinical safety data were found." The single clinical study is a retrospective report of intra-articular injection for chronic knee pain (Results text beginning "Only 1 clinical study could be identified").
PCO-02 safety and pharmacokinetics trial (NCT02637284) (Registry record)
Population or organism: 42 participants planned (estimated)
Design: Registered phase 1 randomized, placebo-controlled trial of an oral formulation (intervention name Bepecin)
Where in the source: Record header: status Unknown, last verified 2015-10; no results posted.
What remains uncertain
- Two people cannot detect uncommon adverse events, and neither report was randomized or blinded.
- The knee-pain series is uncontrolled, rests on patients' own reports and does not report safety outcomes in its abstract.
- No long-term, repeated-dose or product-purity data were found. Products sold as research chemicals may differ from what was tested.
- A registered trial with unknown status and no results gives no safety information.
What would change the answer
- Posted or published results from a registered, controlled human safety trial with a defined adverse-event follow-up.
- Independent analysis of what products labelled BPC-157 actually contain.
Exact gaps
- No controlled human safety data were found. WPF did not search adverse-event reporting systems, so reports there, or their absence, are not assessed. The full text of the knee-pain series was not read.
Where WPF looked for missing evidence
Searched on 2026-11-15 in: PubMed; ClinicalTrials.gov API v2.
- PubMed: BPC-157 / BPC 157 in title or abstract -> 230 records, read for human studies by title and the 2025 systematic review's abstract
- ClinicalTrials.gov: query.intr=BPC-157 -> 4 interventional registrations, none with posted results (NCT07803250, NCT07437547, NCT02637284, NCT07752381; the other three are efficacy, muscle-strain and supplement studies, see the tendon-healing check)
Found: Two small human reports, one uncontrolled knee-pain series and one registered phase 1 trial with unknown status.
Not searched: FDA adverse event reporting (FAERS) and other pharmacovigilance databases; Poison-control and clinic records; Full text of the 230 PubMed records.
Not finding evidence in these searches is not proof that none exists.
Date checked and review status
Checked: · version 1.6.0
Review status: AI-assisted source verification. Human review: none recorded. Human review is pending and has not happened.
Related pages
Profiles: /directory/bpc-157
Cite this check
The citation names the version and an address that keeps returning what was checked, even after a newer version is published.
BPC-157 and safety in humans: WPF found only very small human reports: a two-person intravenous pilot with no adverse effects reported, and a retrospective knee-pain series that reported pain outcomes rather than safety data. That cannot show safety, and the one registered safety trial has no posted results. Verdict: Insufficient evidence. Cited from World Peptide Foundation, Peptide Claims & Evidence, version 1.6.0, claim bpc-157-human-safety, checked 2026-11-15. AI-assisted source verification; human review none recorded.
Page:
https://www.worldpeptidefoundation.org/research/check/bpc-157-human-safety
Versioned record:
https://www.worldpeptidefoundation.org/api/research/claims/bpc-157-human-safety?version=1.6.0
Versioned record: /api/research/claims/bpc-157-human-safety?version=1.6.0